Cargando…
The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients
Genomics and proteomics will improve outcome prediction in cancer and have great potential to help in the discovery of unknown mechanisms of metastasis, ripe for therapeutic exploitation. Current methods of prognosis estimation rely on clinical data, anatomical staging and histopathological features...
Autores principales: | Kelleher, Muireann T., Fruhwirth, Gilbert, Patel, Gargi, Ofo, Enyinnaya, Festy, Frederic, Barber, Paul R., Ameer-Beg, Simon M., Vojnovic, Borivoj, Gillett, Cheryl, Coolen, Anthony, Kéri, György, Ellis, Paul A., Ng, Tony |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778706/ https://www.ncbi.nlm.nih.gov/pubmed/19756916 http://dx.doi.org/10.1007/s11523-009-0116-y |
Ejemplares similares
-
A Multi-Functional Imaging Approach to High-Content Protein Interaction Screening
por: Matthews, Daniel R., et al.
Publicado: (2012) -
HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status
por: Weitsman, Gregory, et al.
Publicado: (2016) -
Fluorescence lifetime endoscopy using TCSPC for the measurement of FRET in live cells
por: Fruhwirth, Gilbert O., et al.
Publicado: (2010) -
High-throughput optical proteomics and breast cancer patient profiling: novel applications to individualise prognosis and treatment
por: Kelleher, MT, et al.
Publicado: (2008) -
Robust Bayesian Fluorescence Lifetime Estimation, Decay Model Selection and Instrument Response Determination for Low-Intensity FLIM Imaging
por: Rowley, Mark I., et al.
Publicado: (2016)